Previous 10 | Next 10 |
home / stock / clabf / clabf news
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the " Company " or " Core One ") announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth Opportunity Corporation) (PBIC) (" PBI...
An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Regular readers of the Emerging Markets Report are clear as to our affinity for mushrooms and psychedelic based companies. We are firm believers in the treatment possibilities ...
VANCOUVER, BC / ACCESSWIRE / April 6, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the " Company " or " Core One ") is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. (" Vocan ") has expanded its product commercialization te...
VANCOUVER, BC / ACCESSWIRE / March 31, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) WKN: A2P8K3) (" Core One " or the " Company "), a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery syst...
VANCOUVER, BC / ACCESSWIRE / March 28, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the " Company ") is pleased to announce that its wholly owned subsidiary Rejuva Mental Health Clinic (the "Clinic") has retained Dr. Stephen Peach as Lead Physician. Dr. Peach...
VANCOUVER, British Columbia, March 22, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that it has filed an application to list its common shares on the Cap...
Core One Labs (CLABF) announces that it has filed an application to list its shares on the Capital Market tier of the Nasdaq stock index.Pending consideration of the company’s application by Nasdaq, Core One’s shares will continue to trade on the Canadian Securities Exchan...
VANCOUVER, British Columbia, March 20, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that it has filed an application to list its common shares on the Cap...
VANCOUVER, BC / ACCESSWIRE / March 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN: A2P8K3) (the " Company ") a research and technology company focused on life sciences and bringing psychedelic medicines to market through novel delivery systems and psychedelic assist...
The Developer of Psychedelic Treatments Enters the Telehealth Space with Access to Close to 80,000 Clinic Patients VANCOUVER, BC / ACCESSWIRE / March 12, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the " Company " or " Core One ") announces tha...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 8, 2024 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN: A3CSSU ) (the " Company " or " Core One "), is pleased to announce that it has entered into a loan agreement (the " Loan Agreement ") with Right Season Investments Corp. (" Right S...
VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the signing of an Initial Agreement (the " Agreement ") with Cube Psytech Corp. (" Cube Psytech ") marking a sig...
VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. (" Core One " or the " Company ") (CNSX: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU ), an emerging leader in the field of neuroscience and psychedelics, is delighted to share the exciting results of its first round of S...